for comparison, annual GLP-1 medication costs are currently estimated at $7,000$8,000, meaning surgery may be more cost-effective over a five-year horizon
Regulations on high-sugar products are increasing across Europe, North America, and Asia
However, most drug classes involved in T2D therapy promote weight gain (insulin, sulfonylureas, and others) [9]
However, variability has been noted between studies, and long-term secretion patterns remain under continued investigation
Journal of Endocrinology, 146(1), 141-148
Because semaglutide and other GLP-1 analogs act in the brain, when taking into account possible adverse effects during GLP-1 treatment, caution may be considered for the influence of semaglutide in the limbic system of the brain during an individualized approach